These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Differentiation of glycine antagonist sites of N-methyl-D-aspartate receptor subtypes. Preferential interaction of CGP 61594 with NR1/2B receptors. Honer M; Benke D; Laube B; Kuhse J; Heckendorn R; Allgeier H; Angst C; Monyer H; Seeburg PH; Betz H; Mohler H J Biol Chem; 1998 May; 273(18):11158-63. PubMed ID: 9556603 [TBL] [Abstract][Full Text] [Related]
13. The N-terminal domains of both NR1 and NR2 subunits determine allosteric Zn2+ inhibition and glycine affinity of N-methyl-D-aspartate receptors. Madry C; Mesic I; Betz H; Laube B Mol Pharmacol; 2007 Dec; 72(6):1535-44. PubMed ID: 17878266 [TBL] [Abstract][Full Text] [Related]
14. Effects of NR1 splicing on NR1/NR3B-type excitatory glycine receptors. Cavara NA; Orth A; Hollmann M BMC Neurosci; 2009 Apr; 10():32. PubMed ID: 19348678 [TBL] [Abstract][Full Text] [Related]
15. Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits. Chandra T; Maier W; König HG; Hirzel K; Kögel D; Schüler T; Chandra A; Demirhan I; Laube B Neuroscience; 2005; 134(1):145-53. PubMed ID: 15964699 [TBL] [Abstract][Full Text] [Related]
16. A mutation in the glycine binding pocket of the N-methyl-D-aspartate receptor NR1 subunit alters agonist efficacy. Wood MW; VanDongen HM; VanDongen AM Brain Res Mol Brain Res; 1999 Nov; 73(1-2):189-92. PubMed ID: 10581413 [TBL] [Abstract][Full Text] [Related]